Nuclear-encoded mitochondrial proteins and their role in cardioprotection

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 7, 2011, Pages 1286-1294

  Boengler, Kerstin ^a   Heusch, Gerd ^a   Schulz, Rainer ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Cardioprotection; Connexin 43; Import; Ischemia reperfusion; Mitochondria; Protein kinases

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CONNEXIN 43; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 10; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL PROTEIN; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C GAMMA; PROTEIN KINASE C THETA; PROTEIN KINASE PIM 1; STAT3 PROTEIN;

CELL NUCLEUS; CYTOSOL; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REPERFUSION INJURY; REVIEW;

ANIMALS; CARDIOTONIC AGENTS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICE; MITOCHONDRIA, HEART; MITOCHONDRIAL PROTEINS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC;

EID: 79957932138     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.01.009     Document Type: Review

References (140)

1. Adlam V.J., Harrison J.C., Porteous C.M., James A.M., Smith R.A., Murphy M.P., Sammut I.A. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J. 2005, 19:1088-1095.
2. Andrukhiv A., Costa A.D., West I.C., Garlid K.D. Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H2067-H2074.
3. Arrell D.K., Elliott S.T., Kane L.A., Guo Y., Ko Y.H., Pedersen P.L., Robinson J., Murata M., Murphy A.M., Marban E., van Eyk J.E. Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ. Res. 2006, 99:706-714.
4. Baines C.P., Goto M., Downey J.M. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J. Mol. Cell. Cardiol. 1997, 29:207-216.
5. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., Brunskill E.W., Sayen M.R., Gotlieb R.A., Dorn G.W., Robbins J., Molkentin J.D. Loss of cyclophiin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, 434:658-662.
6. Baines C.P., Kaiser R.A., Sheiko T., Craigen W.J., Molkentin J.D. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat. Cell Biol. 2007, 9:550-555.
7. Baines C.P., Zhang J., Wang G.-W., Zheng Y.-T., Xiu J.X., Cardwell E.M., Bolli R., Ping P. Mitochondrial PKCe and MAPK form signaling modules in the murine heart. Circ. Res. 2002, 90:390-397.
8. Balaban R.S., Nemoto S., Finkel T. Mitochondria, oxidants, and aging. Cell 2005, 120:483-495.
9. Baseler W.A., Dabkowski E.R., Williamson C.L., Croston T.L., Thapa D., Powell M.J., Razunguwa T.T., Hollander J.M. Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, doi:10.1152/ajpregu.00423.2010.
10. Basso E., Fante L., Fowlkes J., Petronilli V., Forte M.A., Bernardi P. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J. Biol. Chem. 2005, 280:18558-18561.
11. Beardslee M.A., Laing J.G., Beyer E.C., Saffitz J.E. Rapid turnover of connexin43 in the adult rat heart. Circ. Res. 1998, 83:629-635.
12. Becker L.B., Vanden Hoek T.L., Shao Z.-H., Li C.-Q., Schumacker P.T. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am. J. Physiol. 1999, 277(46):H2240-H2246.
13. Bianchi P., Kunduzova O., Masini E., Cambon C., Bani D., Raimondi L., Seguelas M.-H., Nistri S., Colucci W., Leducq N., Parini A. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation 2005, 112:3297-3305.
14. Bodyak N., Kang P.M., Hiromura M., Sulijoadikusumo I., Horikoshi N., Khrapko K., Usheva A. Gene expression profiling of the aging mouse cardiac myocytes. Nucleic Acids Res. 2002, 30:3788-3794.
15. Boengler K., Buechert A., Heinen Y., Roeskes C., Hilfiker-Kleiner D., Heusch G., Schulz R. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ. Res. 2008, 102:131-135.
16. Boengler K., Dodoni G., Rodriguez-Sinovas A., Cabestrero A., Ruiz-Maena M., Gres P., Konietzka I., Lopez-Iglesias C., García-Dorado D., Heusch G., Schulz R. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc. Res. 2005, 67:234-244.
17. Boengler K., Gres P., Cabestrero A., Ruiz-Meana M., Garcia-Dorado D., Heusch G., Schulz R. Prevention of the ischemia-induced decrease in mitochondrial Tom20 content by ischemic preconditioning. J. Mol. Cell. Cardiol. 2006, 41:426-430.
18. Boengler K., Gres P., Dodoni G., Konietzka I., Di L.F., Heusch G., Schulz R. Mitochondrial respiration and membrane potential after low-flow ischemia are not affected by ischemic preconditioning. J. Mol. Cell. Cardiol. 2007, 43:610-615.
19. Boengler K., Heusch G., Schulz R. Mitochondria in postconditioning. Antioxid. Redox. Signal. 2010, DOI:10.1089./ars.2010.3309.
20. Boengler K., Hilfiker-Kleiner D., Drexler H., Heusch G., Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol. Therap. 2008, 120:172-185.
21. Boengler K., Hilfiker-Kleiner D., Heusch G., Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res. Cardiol. 2010, 105:771-785.
22. Boengler K., Konietzka I., Buechert A., Heinen Y., Garcia-Dorado D., Heusch G., Schulz R. Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H1764-H1769.
23. Boengler K., Schulz R., Heusch G. Loss of cardioprotection with ageing. Cardiovasc. Res. 2009, 83:247-261.
24. Boengler K., Stahlhofen S., van de Sand A., Gres P., Ruiz-Meana M., Garcia-Dorado D., Heusch G., Schulz R. Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria. Basic Res. Cardiol. 2009, 104:141-147.
25. Borillo G.A., Mason M., Quijada P., Volkers M., Cottage C., McGregor M., Din S., Fischer K., Gude N., Avitable D., Barlow S., Gustafsson A.B., Glembotski C., Gottlieb R.A., Brown J.H., Sussman M.A. Pim-1 kinase protects mitochondrial integrity in cardiomyocytes. Circ. Res. 2010, 106:1265-1274.
26. Boudina S., Sena S., Theobald H., Sheng X.M., Wright J.J., Hu X.X., Aziz S., Johnson J.I., Bugger H., Zaha V.G., Abel E.D. Mitochondrial energetics in the heart in obesity-related diabetes-direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 2007, 56:2457-2466.
27. Bousette N., Kislinger T., Fong V., Isserlin R., Hewel J.A., Emili A., Gramolini A.O. Large-scale characterization and analysis of the murine cardiac proteome. J. Prot. Res. 2009, 8:1887-1901.
28. Brady N.R., Hamacher-Brady A., Gottlieb R.A. Proapoptotic BCL-2 family members and mitochondrial dysfunction during ischemia/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors. Biochim. Biophys. Acta 2006, 1757:667-678.
29. Budas G.R., Churchill E.N., Disatnik M.-H., Sun L., Mochly-Rosen D. Mitochondrial import of PKCe is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury. Cardiovasc. Res. 2010, 88:83-92.
30. Carpi A., Menabo R., Kaludercic N., Pelicci P., Di L.F., Giorgio M. The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury. Biochim. Biophys. Acta 2009, 1787:744-780.
31. Chacinska A., Koehler C.M., Milenkovic D., Lithgow T., Pfanner N. Importing mitochondrial proteins: machineries and mechanisms. Cell 2009, 138:628-644.
32. Chen C.H., Budas G.R., Churchill E.N., Disatnik M.H., Hurley T.D., Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 2008, 321:1493-1495.
33. Chen L., Hahn H., Wu G., Chen C.-H., Liron T., Schechtman D., Cavallaro G., Banci L., Guo Y., Bolli R., Dorn G.W., Mochly-Rosen D. Opposing cardioprotective actions and parallel hypertrophic effects of dPKC and ePKC. Proc. Natl. Acad. Sci. 2001, 98:11114-11119.
34. Churchill E.N., Disatnik M.H., Mochly-Rosen D. Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2. J. Mol. Cell. Cardiol. 2009, 46:278-284.
35. Clarke S.J., Khaliulin I., Das M., Parker J.E., Heesom K.J., Halestrap A.P. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation. Circ. Res. 2008, 102:1082-1090.
36. Costa A.D., Garlid K.D. Intramitochondrial signaling-interactions among mitoKATP, PKC{epsilon}, ROS, and MPT. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H874-H882.
37. Costa A.D.T., Garlid K.D., West I.C., Lincoln T.M., Downey J.M., Cohen M.V., Critz S.D. Protein kinase G transmits the cardioprotective signal from cytososl to mitochondria. Circ. Res. 2005, 97:329-336.
38. Costa A.D.T., Quinlan C.L., Andrukhiv A., West I.C., Jaburek M., Garlid K.D. The direct physiological effects of mitoKATP opening on heart mitochondria. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H406-H415.
39. Craig E.E., Hood D.A. Influence of aging on protein import into cardiac mitochondria. Am. J. Physiol. Heart Circ. Physiol. 1997, 41:H2983-H2988.
40. Dabkowski E.R., Baseler W.A., Williamson C.L., Powell M., Razunguzwa T.T., Frisbee J.C., Hollander J.M. Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H529-H540.
41. Dabkowski E.R., Williamson C.L., Bukowski V.C., Chapman R.S., Leonard S.S., Peer C.J., Callery P.S., Hollander J.M. Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H359-H369.
42. Das D.K., Maulik N., Sato M., Ray P.S. Reactive oxygen species function as second messenger during ischemic preconditioning of heart. Mol. Cell. Biochem. 1999, 196:59-67.
43. Das S., Wong R., Rajapakse N., Murphy E., Steenbergen C. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ. Res. 2008, 103:983-991.
44. de Brito O.M., Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008, 456:605-610.
45. Di Lisa F., Bernardi P. A CaPful of mechanisms regulating the mitochondrial permeability transition. J. Mol. Cell. Cardiol. 2009, 46:775-780.
46. Di Lisa F., Canton M., Menabo R., Kaludercic N., Bernardi P. Mitochondria and cardioprotection. Heart Fail. Rev. 2007, 12:249-260.
47. Di Lisa F., Kaludercic N., Carpi A., Menabo R., Giorgio M. Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase. Basic Res. Cardiol. 2009, 104:131-139.
48. Dimmer K.S., Scorrano L. (De) constructing mitochondria: what for?. Physiology 2006, 21:233-241.
49. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2001, 82:47-95.
50. Endo T., Yamano K. Multiple pathways for mitochondrial protein traffic. Biol. Chem. 2009, 390:723-730.
51. Fan A.C., Bhangoo M.K., Young J.C. Hsp90 functions in the targeting and outer membrane translocation steps of Tom70-mediated mitochondrial import. J. Biol. Chem. 2006, 281:33313-33324.
52. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 1995, 64:97-112.
53. Fuglesteg B.N., Suleman N., Tiron C., Kanhema T., Lacerda L., Andreasen T.V., Sack M.N., Jonassen A.K., Mjos O.D., Opie L.H., Lecour S. Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion. Basic Res. Cardiol. 2008, 103:444-453.
54. Giorgio M., Migliaccio E., Orsini F., Paolucci D., Moroni M., Contursi C., Pelliccia G., Luzi L., Minucci S., Marcaccio M., Pinton P., Rizzuto R., Bernardi P., Paolucci F., Pelicci P.G. Electron transfer between cytochrome c and p66(Shc) generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005, 122:221-233.
55. Gomez L., Paillard M., Thibault H., Derumeaux G., Ovize M. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008, 117:2761-2768.
56. Goodman M.D., Koch S.E., Fuller-Bicer G.A., Butler K.L. Regulating RISK: a role for JAK-STAT signaling in postconditioning?. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1649-H1656.
57. Gottlieb R.A., Carreira R.S. Autophagy in health and disease. 5. Mitophagy as a way of life. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:C203-C210.
58. Gough D.J., Corlett A., Schlessinger K., Wegrzyn J., Larner A.C., Levy D.E. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009, 324:1713-1716.
59. Gray M.O., Karliner J.S., Mochly-Rosen D. A selective e-protein kinase c antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J. Biol. Chem. 1997, 272:30945-30951.
60. Grey J.Y., Connor M.K., Gordon J.W., Yano M., Mori M., Hood D.A. Tom20-mediated mitochondrial protein import in muscle cells during differentiation. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:C1393-C1400.
61. Guo D.H., Nguyen T., Ogbi M., Tawfik H., Ma G.C., Yu Q.L., Caldwell R.W., Johnson J.A. Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2219-H2230.
62. Hamblin M., Friedman D.B., Hill S., Caprioli R.M., Smith H.M., Hill M.F. Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy. J. Mol. Cell. Cardiol. 2007, 42:884-895.
63. Hausenloy D.J., Baxter G., Bell R., BØtker H.E., Davidson S.M., Downey J., Heusch G., Kitakaze M., Lecour S., Mentzer R., Mocanu M.M., Ovize M., Schulz R., Shannon R., Walker M., Walkinshaw G., Yellon D.M. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res. Cardiol. 2010, 105:677-686.
64. Heinzel F.R., Luo Y., Li X., Boengler K., Buechert A., García-Dorado D., Di Lisa F., Schulz R., Heusch G. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ. Res. 2005, 97:583-586.
65. Heusch G., Boengler K., Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 2008, 118:1915-1919.
66. Heusch G., Boengler K., Schulz R. Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection. Basic Res. Cardiol. 2010, 105:151-154.
67. Heusch G., Büchert A., Feldhaus S., Schulz R. No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res. Cardiol. 2006, 101:354-356.
68. Hollander J.M., Lin K.M., Scott B.T., Dillmann W.H. Overexpression of PHGPx and HSP60/10 protects against ischemia/reoxygenation injury. Free Rad. Biol. Med. 2003, 35:742-751.
69. Inagaki K., Hahn H.S., Dorn G.W., Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with d-protein kinase C inhibitor and e-Protein kinase C activator. Circulation 2003, 108:369-875.
70. Jaburek M., Costa A.D., Burton J.R., Costa C.L., Garlid K.D. Mitochondrial PKC epsilon and mitochondrial ATP-sensitive K+channel copurify and coreconstitute to form a functioning signaling module in proteoliposomes. Circ. Res. 2006, 99:878-883.
71. Juhaszova M., Zorov D.B., Kim S.-H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., Sollott S.J. Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 2004, 113:1535-1549.
72. Juhaszova M., Zorov D.B., Yaniv Y., Nuss H.B., Wang S., Sollott S.J. Role of glycogen synthase kinase-3beta in cardioprotection. Circ. Res. 2009, 104:1240-1252.
73. Kevin L.G., Camara A.K.S., Riess M.L., Novalija E., Stowe D.F. Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H566-H574.
74. Kokoszka J.E., Waymire K.G., Levy S.E., Sligh J.E., Cai J., Jones D.P., MacGregor G.R., Wallace D.C. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004, 427:461-465.
75. Kupatt C., Hinkel R., Horstkotte J., Deiβ M., von Brühl M.-L., Bilzer M., Boekstegers P. Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model. Cardiovasc. Res. 2004, 61:530-537.
76. Lau S., Patnaik N., Sayen R., Mestril R. Simultaneous overexpression of two stress proteins in rat cardiomyocytes and myogenic cells confers protection against ischemia-induced injury. Circulation 1997, 96:2287-2294.
77. Lesnefsky E.J., Tandler B., Ye J., Slabe T.J., Turkaly J., Hoppel C.L. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am. J. Physiol. Heart Circ. Physiol. 1997, 273:H1544-H1554.
78. Lin K.M., Hollander J.M., Kao V.Y., Lin B., Macpherson L., Dillmann W.H. Myocyte protection by 10 kD heat shock protein (Hsp10) involves the mobile loop and attenuation of the Ras GTP-ase pathway. FASEB J. 2004, 18:1004-1006.
79. Lin K.M., Lin B., Lian I.Y., Mestril R., Scheffler I.E., Dillmann W.H. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation 2001, 103:1787-1792.
80. Liu G.S., Cohen M.V., Mochly-Rosen D., Downey J.M. Protein kinase C-e is responsible for the protection of preconditioning in rabbit cardiomyocytes. J. Mol. Cell. Cardiol. 1999, 31:1937-1948.
81. Lu G., Haider H.K., Jiang S., Ashraf M. Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation 2009, 119:2587-2596.
82. Lu G., Haider H.K., Porollo A., Ashraf M. Mitochondria specific transgenic overexpression of connexin-43 stimulates preconditioning induced cytoprotection of stem cells. Cardiovasc. Res. 2010, 88:277-286.
83. Maack C., O'Rourke B. Excitation-contraction coupling and mitochondrial energetics. Basic Res. Cardiol. 2007, 102:369-392.
84. MacKenzie J.A., Payne R.M. Mitochondrial protein import and human health and disease. Biochim. Biophys. Acta 2007, 1772:509-523.
85. Miki T., Miura T., Hotta H., Tanno M., Yano T., Sato T., Terashima Y., Takada A., Ishikawa S., Shimamoto K. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3 beta-mediated suppression of mitochondrial permeability transition. Diabetes 2009, 58:2863-2872.
86. Millar D.G., Shore G.C. Signal anchor sequence insertion into the outer mitochondrial membrane. Comparison with porin and the matrix protein targeting pathway. J. Biol. Chem. 1996, 271:25823-25829.
87. Miro-Casas E., Ruiz-Meana M., Agullo E., Stahlhofen S., Rodriguez-Sinovas A., Cabestrero A., Jorge I., Torre I., Vazquez J., Boengler K., Schulz R., Heusch G., Garcia-Dorado D. Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake. Cardiovasc. Res. 2009, 83:747-756.
88. Muraski J.A., Rota M., Misao Y., Fransioli J., Cottage C., Gude N., Esposito G., Delucchi F., Arcarese M., Alvarez R., Siddiqi S., Emmanuel G.N., Wu W., Fischer K., Martindale J.J., Glembotski C.C., Leri A., Kajstura J., Magnuson N., Berns A., Beretta R.M., Houser S.R., Schaefer E.M., Anversa P., Sussman M.A. Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat. Med. 2007, 13:1467-1475.
89. Murphy E., Steenbergen C. Preconditioning: the mitochondrial connection. Annu. Rev. Physiol. 2007, 69:51-67.
90. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
91. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
92. Newton A.C. Protein kinase C: poised to signal. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E395-E402.
93. Nishihara M., Miura T., Miki T., Sakamoto J., Tanno M., Kobayashi H., Ikeda Y., Ohori K., Takahashi A., Shimamoto K. Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phsphorylation of glycogen synthase kinase-3β. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H748-H755.
94. Nishihara M., Miura T., Miki T., Tanno M., Yano T., Naitoh K., Ohori K., Hotta H., Terashima Y., Shimamoto K. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J. Mol. Cell. Cardiol. 2007, 43:564-570.
95. Nishino Y., Webb I.G., Davidson S.M., Ahmed A.I., Clark J.E., Jacquet S., Shah A.M., Miura T., Yellon D.M., Avkiran M., Marber M.S. Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ. Res. 2008, 103:307-314.
96. Ohnuma Y., Miura T., Miki T., Tanno M., Kuno A., Tsuchida A., Shimamoto K. Opening of mitochondrial KATP channel occurs downstream of PKC-e activation in the mechanism of preconditioning. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H440-H447.
97. Ong S.B., Hausenloy D.J. Mitochondrial morphology and cardiovascular disease. Cardiovasc. Res. 2010, 88:16-29.
98. Ong S.B., Subrayan S., Lim S.Y., Yellon D.M., Davidson S.M., Hausenloy D.J. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010, 121:2012-2022.
99. Ovize M., Baxter G.F., Di Lisa F., Ferdinandy P., Garcia-Dorado D., Hausenloy D.J., Heusch G., Vinten-Johansen J., Yellon D.M., Schulz R. Postconditioning and protection from reperfusion injury: where do we stand?. Cardiovasc. Res. 2010, 87:406-423.
100. Pain T., Yang X.-M., Critz S.D., Yue Y., Nakano A., Liu G.S., Heusch G., Cohen M.V., Downey J.M. Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Circ. Res. 2000, 87:460-466.
101. Paradies G., Petrosillo G., Pistolese M., Di Venosa N., Federici A., Ruggiero F.M. Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart. Involvement of reactive oxygen species and cardiolipin. Circ. Res. 2004, 94:53-59.
102. Penna C., Perrelli M.G., Raimondo S., Tullio F., Merlino A., Moro F., Geuna S., Mancardi D., Pagliaro P. Postconditioning induces an anti-apoptotic effect and preserves mitochondrial integrity in isolated rat hearts. Biochim. Biophys. Acta 2009, 1787:794-801.
103. Ping P., Zhang Y., Tang X.-L., Manchikalapudi S., Cao X., Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms e and n in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ. Res. 1997, 81:404-414.
104. Piot C., Croisille P., Staat P., Thibault H., Rioufol G., Mewton N., Elbelghiti R., Cung T.T., Bonnefoy E., Angoulvant D., Macia C., Raczka F., Sportouch C., Gahide G., Finet G., Andre-Fouet X., Revel D., Kirkorian G., Monassier J.-P., Derumeaux G., Ovize M. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N. Engl. J. Med. 2008, 359:473-481.
105. Piper H.M., Kasseckert S., Abdallah Y. The sarcoplasmic reticulum as the primary target of reperfusion protection. Cardiovasc. Res. 2006, 70:170-173.
106. Robin E., Guzy R.D., Loor G., Iwase H., Waypa G.B., Marks J.D., Hoek T.L., Schumacker P.T. Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J. Biol. Chem. 2007, 282:19133-19143.
107. Rodriguez-Sinovas A., Boengler K., Cabestrero A., Gres P., Morente M., Ruiz-Meana M., Konietzka I., Miró E., Totzeck A., Heusch G., Schulz R., Garcia-Dorado D. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ. Res. 2006, 99:93-101.
108. Rosca M.G., Vazquez E.J., Kerner J., Parland W., Chandler M.P., Stanley W., Sabbah H.N., Hoppel C.L. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc. Res. 2008, 80:30-39.
109. Rottlaender D., Boengler K., Wolny M., Michels G., Endres-Becker J., Motloch L.J., Schwaiger A., Buechert A., Schulz R., Heusch G., Hoppe U.C. Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes. J. Clin. Invest. 2010, 120:1441-1453.
110. Ruiz-Meana M., Fernandez-Sanz C., Garcia-Dorado D. The SR-mitochondria interaction: a new player in cardiac pathophysiology. Cardiovasc. Res. 2010, 88:30-39.
111. Saurin A.T., Pennington D.J., Raat N.J.H., Latchman D.S., Owen M.J., Marber M.S. Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc. Res. 2002, 55:672-680.
112. Schulz R., Boengler K., Totzeck A., Luo Y., Garcia-Dorado D., Heusch G. Connexin 43 in ischemic pre- and postconditioning. Heart Fail. Rev. 2007, 12:261-266.
113. Schulz R., Gres P., Skyschally A., Duschin A., Belosjorow S., Konietzka I., Heusch G. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J. 2003, 17:1355-1357.
114. Shen X., Zheng S.R., Thongboonkerd V., Xu M., Pierce W.M., Klein J.B., Epstein P.N. Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E896-E905.
115. Sivaraman V., Hausenloy D.J., Kolvekar S., Hayward M., Yap J., Lawrence D., Di S.C., Yellon D.M. The divergent roles of protein kinase C epsilon and delta in simulated ischaemia-reperfusion injury in human myocardium. J. Mol. Cell. Cardiol. 2009, 46:758-764.
116. Skyschally A., van Caster P., Boengler K., Gres P., Musiolik J., Schilawa D., Schulz R., Heusch G. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ. Res. 2009, 104:15-18.
117. Smith R.M., Suleman N., Lacerda L., Opie L.H., Akira S., Chien K.R., Sack M.N. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovasc. Res. 2004, 63:611-616.
118. Söhl G., Willecke K. Gap junctions and the connexin protein family. Cardiovasc. Res. 2004, 62:228-232.
119. Solan J.L., Lampe P.D. Connexin43 phosphorylation: structural changes and biological effects. Biochem. J. 2009, 419:261-272.
120. Stumpner J., Redel A., Kellermann A., Lotz C.A., Blomeyer C.A., Smul T.M., Kehl F., Roewer N., Lange M. Differential role of Pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction. Anesthesiology 2009, 111:1257-1264.
121. Suleman N., Somers S., Smith R., Opie L.H., Lecour S.C. Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc. Res. 2008, 79:127-133.
122. Takahashi M., Chesley A., Freyssenet D., Hood D.A. Contractile activity-induced adaptations in the mitochondrial protein import system. Am. J. Physiol. Heart Circ. Physiol. 1998, 274:C1380-C1387.
123. Tamareille S., Ghaboura N., Treguer F., Khachman D., Croue A., Henrion D., Furber A., Prunier F. Myocardial reperfusion injury management: erythropoietin compared with postconditioning. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H2035-H2043.
124. Taylor S.W., Fahy E., Zhang B., Glenn G.M., Warnock D.E., Wiley S., Murphy A.N., Gaucher S.P., Capaldi R., Gibson B.W., Gosh S.S. Characterization of the human heart mitochondrial proteome. Nat. Biotechnol. 2003, 21:281-286.
125. Tong H., Imahashi K., Steenbergen C., Murphy E. Phosphorylation of glycogen synthase kinase-3β during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ. Res. 2002, 90:374-376.
126. Totzeck A., Boengler K., van de Sand A., Konietzka I., Gres P., Garcia-Dorado D., Heusch G., Schulz R. No impact of protein phosphatases on connexin 43 phosphorylation in ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H2106-H2112.
127. Turko I.V., Murad F. Quantitative protein profiling in heart mitochondria from diabetic rats. J. Biol. Chem. 2003, 278:35844-35849.
128. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552:335-344.
129. Uecker M., Da Silva R., Grampp T., Pasch T., Schaub M.C., Zaugg M. Translocation of protein kinase C isoforms to subcellular targets in ischemic and anesthetic preconditioning. Anesthesiology 2003, 99:138-147.
130. Vanden Hoek T.L., Becker L.B., Shao Z.-H., Li C.-Q., Schumacker P.T. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ. Res. 2000, 86:541-548.
131. Vanden Hoek T.L., Li C., Shao Z., Schumacker P.T., Becker L.B. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J. Mol. Cell. Cardiol. 1997, 29:2571-2583.
132. Vinten-Johansen J., Zhao Z.-Q., Zatta A.J., Kin H., Halkos M.E., Kerendi F. Postconditioning. A new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res. Cardiol. 2005, 295:295-310.
133. Voos W., Martin H., Krimmer T., Pfanner N. Mechanisms of protein translocation into mitochondria. Biochim. Biophys. Acta 1999, 1422:235-254.
134. Wegrzyn J., Potla R., Chwae Y.J., Sepuri N.B., Zhang Q., Koeck T., Derecka M., Szczepanek K., Szelag M., Gornicka A., Moh A., Moghaddas S., Chen Q., Bobbili S., Cichy J., Dulak J., Baker D.P., Wolfman A., Stuehr D., Hassan M.O., Fu X.Y., Avadhani N., Drake J.I., Fawcett P., Lesnefsky E.J., Larner A.C. Function of mitochondrial Stat3 in cellular respiration. Science 2009, 323:793-797.
135. Williamson C.L., Dabkowski E.R., Dillmann W.H., Hollander J.M. Mitochondria protection from hypoxia/reoxygenation injury with mitochondria heat shock protein 70 overexpression. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H249-H256.
136. Wong R., Aponte A.M., Steenbergen C., Murphy E. Cardioprotection leads to novel changes in the mitochondrial proteome. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H75-H91.
137. Zatta A.J., Kin H., Lee G., Wang N., Jiang R., Lust R., Reeves J.G., Mykytenko J., Guyton R.A., Zhao Z.Q., Vinten-Johansen J. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc. Res. 2006, 70:315-324.
138. Zhang J., Li X., Mueller M., Wang Y., Zong C., Deng N., Vondriska T.M., Liem D.A., Yang J.I., Korge P., Honda H., Weiss J.N., Apweiler R., Ping P. Systematic characterization of the murine mitochondrial proteome using functionally validated cardiac mitochondria. Proteomics 2008, 8:1564-1575.
139. Zhao Z.-Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.-P., Guyton R.A., Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H579-H588.
140. Zou H., Li Y.C., Liu H.S., Wang X.D. An APAF-1 center dot cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 1999, 274:11549-11556.